FDA Approves First Generic Version of Alzheimer’s Drug Aducanumab
FDA Approves First Generic Version of Alzheimer’s Drug Aducanumab: What Does This Mean for Patients? The FDA approves the first generic version of Aducanumab. Aducanumab is a drug that treats Alzheimer’s disease. This is a significant development, as it could make the drug more affordable for patients. Aducanumab is a monoclonal antibody that works by […]